Dentists' attitudes, behaviors, and barriers related to tobacco‐use cessation in the dental setting
…, S Silverstein, R Meckstroth, B Heckman… - Journal of public …, 2013 - Wiley Online Library
Objective: This study assessed attitudes, behaviors, and barriers among general dentists in
California, Pennsylvania, and West Virginia, related to patient tobacco cessation counseling. …
California, Pennsylvania, and West Virginia, related to patient tobacco cessation counseling. …
Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants
…, DH Watts, P Jean-Philippe, B Heckman… - Antimicrobial agents …, 2011 - Am Soc Microbiol
Tenofovir (TFV) is effective in preventing simian immunodeficiency virus (SIV) transmission
in a macaque model, is available as the oral agent tenofovir disoproxil fumarate (TDF), and …
in a macaque model, is available as the oral agent tenofovir disoproxil fumarate (TDF), and …
Oral health prevention and toddler well-child care: routine integration in a safety net system
METHODS: Over 3 years, the team developed clinical policies, educational materials, billing,
and support systems to facilitate implementation in the primary care setting. A pilot study …
and support systems to facilitate implementation in the primary care setting. A pilot study …
Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy
…, R Hazra, L Serchuck, BE Heckman… - The Pediatric …, 2009 - journals.lww.com
Background: With increasing recognition of the benefits of early antiretroviral therapy initiation
in perinatally HIV-infected infants, data are needed regarding the pharmacokinetics (PK), …
in perinatally HIV-infected infants, data are needed regarding the pharmacokinetics (PK), …
Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human …
…, SA Spector, MD Decker, BE Heckman… - The Pediatric …, 2010 - journals.lww.com
Background: Quadrivalent meningococcal polysaccharide conjugate vaccine (MCV4) is
routinely recommended for healthy youth in the United States, but there are no data about its …
routinely recommended for healthy youth in the United States, but there are no data about its …
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT …
…, K Calabrese, K Baltrusaitis, B Heckman… - The Lancet …, 2024 - thelancet.com
Background Long-acting injectable cabotegravir and rilpivirine have demonstrated safety,
acceptability, and efficacy in adults living with HIV-1. The IMPAACT 2017 study (MOCHA study…
acceptability, and efficacy in adults living with HIV-1. The IMPAACT 2017 study (MOCHA study…
[HTML][HTML] Randomized controlled trial of a remote coaching mHealth adherence intervention in youth living with HIV
…, A Dunlap, R Goolsby, MM Johnson, B Heckman… - AIDS and Behavior, 2022 - Springer
Youth living with HIV (YLWH) in the US have low rates of viral suppression (VS). In a prospective
randomized clinical trial (ATN152) that enrolled 89 YLWH on antiretroviral therapy (ART…
randomized clinical trial (ATN152) that enrolled 89 YLWH on antiretroviral therapy (ART…
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV …
…, SR Mathiba, A Adeyeye, JH Moye, B Heckman… - The Lancet …, 2024 - thelancet.com
Background Combined intramuscular long-acting cabotegravir and long-acting rilpivirine
constitute the first long-acting combination antiretroviral therapy (ART) regimen approved for …
constitute the first long-acting combination antiretroviral therapy (ART) regimen approved for …
Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women
…, DH Watts, T Fenton, B Heckman… - Clinical infectious …, 2013 - academic.oup.com
Background. Pregnant women infected with human immunodeficiency virus (HIV) may have
particular vulnerability to 2009 pandemic H1N1 influenza (pH1N1) infection. The safety and …
particular vulnerability to 2009 pandemic H1N1 influenza (pH1N1) infection. The safety and …
[HTML][HTML] Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial
…, M Tomu, L Fairlie, K George, B Heckman… - BMC infectious …, 2022 - Springer
Background Tenofovir disoproxil fumarate (TDF) in combination with other antiretroviral (ARV)
drugs has been in clinical use for HIV treatment since its approval in 2001. Although the …
drugs has been in clinical use for HIV treatment since its approval in 2001. Although the …